ID   SCMC3_HUMAN             Reviewed;         468 AA.
AC   Q9BV35; B4DGB6; Q4LBC2; Q705K3; Q86Y43; Q8N2N4; Q96NQ4;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   28-JUN-2023, entry version 173.
DE   RecName: Full=Mitochondrial adenyl nucleotide antiporter SLC25A23 {ECO:0000305|PubMed:15123600};
DE   AltName: Full=Mitochondrial ATP-Mg/Pi carrier protein 2 {ECO:0000303|PubMed:15123600};
DE   AltName: Full=Short calcium-binding mitochondrial carrier protein 3 {ECO:0000303|PubMed:15054102};
DE            Short=SCaMC-3 {ECO:0000303|PubMed:15054102};
DE   AltName: Full=Solute carrier family 25 member 23 {ECO:0000312|HGNC:HGNC:19375};
GN   Name=SLC25A23 {ECO:0000312|HGNC:HGNC:19375};
GN   Synonyms=APC2 {ECO:0000303|PubMed:15123600}, MCSC2, SCAMC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15054102; DOI=10.1074/jbc.m401417200;
RA   del Arco A., Satrustegui J.;
RT   "Identification of a novel human subfamily of mitochondrial carriers with
RT   calcium-binding domains.";
RL   J. Biol. Chem. 279:24701-24713(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TRANSPORTER ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   TOPOLOGY, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=15123600; DOI=10.1074/jbc.m400445200;
RA   Fiermonte G., De Leonardis F., Todisco S., Palmieri L., Lasorsa F.M.,
RA   Palmieri F.;
RT   "Identification of the mitochondrial ATP-Mg/Pi transporter. Bacterial
RT   expression, reconstitution, functional characterization, and tissue
RT   distribution.";
RL   J. Biol. Chem. 279:30722-30730(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   CALCIUM-BINDING, AND TISSUE SPECIFICITY.
RX   PubMed=15716113; DOI=10.1016/j.gene.2004.11.028;
RA   Bassi M.T., Manzoni M., Bresciani R., Pizzo M.T., Della Monica A.,
RA   Barlati S., Monti E., Borsani G.;
RT   "Cellular expression and alternative splicing of SLC25A23, a member of the
RT   mitochondrial Ca2+-dependent solute carrier gene family.";
RL   Gene 345:173-182(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala, Cerebellum, and Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 413-468 (ISOFORM 4), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=15801905; DOI=10.1042/bj20050283;
RA   Del Arco A.;
RT   "Novel variants of human SCaMC-3, an isoform of the ATP-Mg/P(i)
RT   mitochondrial carrier, generated by alternative splicing from 3'-flanking
RT   transposable elements.";
RL   Biochem. J. 389:647-655(2005).
RN   [8]
RP   FUNCTION, INTERACTION WITH MCU AND MICU1, AND MUTAGENESIS OF ASP-22;
RP   GLU-33; ASP-90 AND GLU-101.
RX   PubMed=24430870; DOI=10.1091/mbc.e13-08-0502;
RA   Hoffman N.E., Chandramoorthy H.C., Shanmughapriya S., Zhang X.Q.,
RA   Vallem S., Doonan P.J., Malliankaraman K., Guo S., Rajan S., Elrod J.W.,
RA   Koch W.J., Cheung J.Y., Madesh M.;
RT   "SLC25A23 augments mitochondrial Ca(2+) uptake, interacts with MCU, and
RT   induces oxidative stress-mediated cell death.";
RL   Mol. Biol. Cell 25:936-947(2014).
RN   [9]
RP   FUNCTION.
RX   PubMed=28695448; DOI=10.1007/s10863-017-9721-0;
RA   Monne M., Daddabbo L., Giannossa L.C., Nicolardi M.C., Palmieri L.,
RA   Miniero D.V., Mangone A., Palmieri F.;
RT   "Mitochondrial ATP-Mg/phosphate carriers transport divalent inorganic
RT   cations in complex with ATP.";
RL   J. Bioenerg. Biomembr. 49:369-380(2017).
CC   -!- FUNCTION: Electroneutral antiporter that mediates the transport of
CC       adenine nucleotides through the inner mitochondrial membrane.
CC       Originally identified as an ATP-magnesium/inorganic phosphate
CC       antiporter, it also acts as a broad specificity adenyl nucleotide
CC       antiporter. By regulating the mitochondrial matrix adenine nucleotide
CC       pool could adapt to changing cellular energetic demands and indirectly
CC       regulate adenine nucleotide-dependent metabolic pathways
CC       (PubMed:15123600). Also acts as a regulator of mitochondrial calcium
CC       uptake and can probably transport trace amounts of other divalent metal
CC       cations in complex with ATP (PubMed:24430870, PubMed:28695448). In
CC       vitro, a low activity is also observed with guanyl and pyrimidine
CC       nucleotides (PubMed:15123600). {ECO:0000269|PubMed:15123600,
CC       ECO:0000269|PubMed:24430870, ECO:0000269|PubMed:28695448}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP(out) + Mg(2+)(out) + phosphate(in) = ATP(in) + Mg(2+)(in)
CC         + phosphate(out); Xref=Rhea:RHEA:65840, ChEBI:CHEBI:18420,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP(out) + H(+)(out) + phosphate(in) = ADP(in) + H(+)(in) +
CC         phosphate(out); Xref=Rhea:RHEA:65844, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AMP(out) + phosphate(in) = AMP(in) + phosphate(out);
CC         Xref=Rhea:RHEA:70259, ChEBI:CHEBI:43474, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP(out) + 2 H(+)(out) + phosphate(in) = ATP(in) + 2 H(+)(in)
CC         + phosphate(out); Xref=Rhea:RHEA:72035, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP(out) + dADP(in) = ADP(in) + dADP(out);
CC         Xref=Rhea:RHEA:72855, ChEBI:CHEBI:57667, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP(out) + ATP(in) + H(+)(out) + Mg(2+)(in) = ADP(in) +
CC         ATP(out) + H(+)(in) + Mg(2+)(out); Xref=Rhea:RHEA:73659,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:18420, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP(out) + diphosphate(in) = ADP(in) + diphosphate(out);
CC         Xref=Rhea:RHEA:73671, ChEBI:CHEBI:33019, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ADP(out) + dAMP(in) + H(+)(out) = ADP(in) + dAMP(out) +
CC         H(+)(in); Xref=Rhea:RHEA:73675, ChEBI:CHEBI:15378, ChEBI:CHEBI:58245,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-AMP(in) + ADP(out) + H(+)(out) = 3'-AMP(out) + ADP(in) +
CC         H(+)(in); Xref=Rhea:RHEA:73679, ChEBI:CHEBI:15378, ChEBI:CHEBI:60880,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dAMP(out) + phosphate(in) = dAMP(in) + phosphate(out);
CC         Xref=Rhea:RHEA:73687, ChEBI:CHEBI:43474, ChEBI:CHEBI:58245;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3'-AMP(out) + phosphate(in) = 3'-AMP(in) + phosphate(out);
CC         Xref=Rhea:RHEA:73691, ChEBI:CHEBI:43474, ChEBI:CHEBI:60880;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dADP(out) + H(+)(out) + phosphate(in) = dADP(in) + H(+)(in) +
CC         phosphate(out); Xref=Rhea:RHEA:73695, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:57667;
CC         Evidence={ECO:0000269|PubMed:15123600};
CC   -!- ACTIVITY REGULATION: Activated by an increase in cytosolic calcium
CC       levels that induce a conformational change of the N-terminal regulatory
CC       domain, uncapping the channel and allowing transport (By similarity).
CC       Inhibited by bathophenanthroline, mersalyl, p-hydroxymercuribenzoate,
CC       bromcresol purple, tannic acid, pyridoxal 5'-phosphate and p-
CC       hydroxymercuribenzoate (PubMed:15123600).
CC       {ECO:0000250|UniProtKB:Q6NUK1, ECO:0000269|PubMed:15123600}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.3 mM for AMP {ECO:0000269|PubMed:15123600};
CC         KM=0.54 mM for ADP {ECO:0000269|PubMed:15123600};
CC         KM=0.31 mM for ATP {ECO:0000269|PubMed:15123600};
CC         KM=0.22 mM for ATP-Mg {ECO:0000269|PubMed:15123600};
CC         KM=1.4 mM for Pi {ECO:0000269|PubMed:15123600};
CC         Vmax=68 umol/min/g enzyme for AMP antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=73 umol/min/g enzyme for ADP antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=65 umol/min/g enzyme for ATP antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=79 umol/min/g enzyme for ATP-Mg antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=70 umol/min/g enzyme for inorganic phosphate antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=37 umol/min/g enzyme for ATP-Mg:ATP-Mg antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=34 umol/min/g enzyme for ATP-Mg:ATP antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=32 umol/min/g enzyme for ATP-Mg:inorganic phosphate antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=42 umol/min/g enzyme for ATP:ATP-Mg antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=35 umol/min/g enzyme for ATP:ATP antiport
CC         {ECO:0000269|PubMed:15123600};
CC         Vmax=28 umol/min/g enzyme for ATP:inorganic phosphate antiport
CC         {ECO:0000269|PubMed:15123600};
CC   -!- SUBUNIT: Interacts with MCU (PubMed:24430870). Interacts with MICU1
CC       (PubMed:24430870). {ECO:0000269|PubMed:24430870}.
CC   -!- INTERACTION:
CC       Q9BV35; Q92624: APPBP2; NbExp=3; IntAct=EBI-2933255, EBI-743771;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000305|PubMed:15054102, ECO:0000305|PubMed:15123600,
CC       ECO:0000305|PubMed:15716113}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=SCaMC-3a;
CC         IsoId=Q9BV35-1; Sequence=Displayed;
CC       Name=2; Synonyms=SCaMC-3b;
CC         IsoId=Q9BV35-2; Sequence=VSP_031075;
CC       Name=3; Synonyms=SCaMC-3c;
CC         IsoId=Q9BV35-3; Sequence=VSP_031074, VSP_031076;
CC       Name=4; Synonyms=SCaMC-3d;
CC         IsoId=Q9BV35-4; Sequence=VSP_031076;
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in most tissues examined,
CC       with highest expression in brain, skeletal muscle and pancreas.
CC       {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600,
CC       ECO:0000269|PubMed:15716113}.
CC   -!- DOMAIN: The regulatory N-terminal domain/NTD, binds calcium in the
CC       mitochondrial intermembrane space and regulates the antiporter activity
CC       of the transmembrane domain/TMD. In absence of calcium, the apo form of
CC       the N-terminal domain is intrinsically disordered and binds to the
CC       transmembrane domain, inhibiting the transporter activity. Binding of
CC       calcium leads to a major conformational change and abolishes the
CC       interaction with the transmembrane domain and the inhibition of the
CC       transporter activity. {ECO:0000250|UniProtKB:Q6NUK1}.
CC   -!- DOMAIN: The C-terminal mitochondrial carrier domain/transmembrane
CC       domain/TMD bears the transmembrane transporter activity.
CC       {ECO:0000250|UniProtKB:Q6NUK1}.
CC   -!- DOMAIN: Linker region/H9 could directly block the transport of
CC       substrates across the transporter. {ECO:0000250|UniProtKB:Q6NUK1}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB70825.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC11071.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ619988; CAF04494.1; -; mRNA.
DR   EMBL; AJ619962; CAF04059.1; -; mRNA.
DR   EMBL; AJ512835; CAD55563.1; -; mRNA.
DR   EMBL; AY750170; AAU95077.1; -; mRNA.
DR   EMBL; AK054901; BAB70825.1; ALT_INIT; mRNA.
DR   EMBL; AK074579; BAC11071.1; ALT_INIT; mRNA.
DR   EMBL; AK294514; BAG57727.1; -; mRNA.
DR   EMBL; CH471139; EAW69087.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69089.1; -; Genomic_DNA.
DR   EMBL; BC001656; AAH01656.1; -; mRNA.
DR   EMBL; AJ879082; CAI51684.1; -; mRNA.
DR   EMBL; AJ879083; CAI51685.1; -; mRNA.
DR   CCDS; CCDS32882.1; -. [Q9BV35-1]
DR   RefSeq; NP_077008.2; NM_024103.2. [Q9BV35-1]
DR   AlphaFoldDB; Q9BV35; -.
DR   SMR; Q9BV35; -.
DR   BioGRID; 122533; 36.
DR   IntAct; Q9BV35; 20.
DR   STRING; 9606.ENSP00000301454; -.
DR   TCDB; 2.A.29.23.5; the mitochondrial carrier (mc) family.
DR   GlyGen; Q9BV35; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BV35; -.
DR   PhosphoSitePlus; Q9BV35; -.
DR   BioMuta; SLC25A23; -.
DR   DMDM; 167016556; -.
DR   EPD; Q9BV35; -.
DR   jPOST; Q9BV35; -.
DR   MassIVE; Q9BV35; -.
DR   MaxQB; Q9BV35; -.
DR   PaxDb; Q9BV35; -.
DR   PeptideAtlas; Q9BV35; -.
DR   ProteomicsDB; 79158; -. [Q9BV35-1]
DR   ProteomicsDB; 79159; -. [Q9BV35-2]
DR   ProteomicsDB; 79160; -. [Q9BV35-3]
DR   ProteomicsDB; 79161; -. [Q9BV35-4]
DR   Antibodypedia; 24155; 106 antibodies from 19 providers.
DR   DNASU; 79085; -.
DR   Ensembl; ENST00000264088.8; ENSP00000264088.3; ENSG00000125648.15. [Q9BV35-3]
DR   Ensembl; ENST00000301454.9; ENSP00000301454.3; ENSG00000125648.15. [Q9BV35-1]
DR   Ensembl; ENST00000334510.9; ENSP00000334537.4; ENSG00000125648.15. [Q9BV35-2]
DR   GeneID; 79085; -.
DR   KEGG; hsa:79085; -.
DR   MANE-Select; ENST00000301454.9; ENSP00000301454.3; NM_024103.3; NP_077008.2.
DR   UCSC; uc002mex.2; human. [Q9BV35-1]
DR   AGR; HGNC:19375; -.
DR   CTD; 79085; -.
DR   DisGeNET; 79085; -.
DR   GeneCards; SLC25A23; -.
DR   HGNC; HGNC:19375; SLC25A23.
DR   HPA; ENSG00000125648; Tissue enhanced (brain).
DR   MIM; 608746; gene.
DR   neXtProt; NX_Q9BV35; -.
DR   OpenTargets; ENSG00000125648; -.
DR   PharmGKB; PA134932456; -.
DR   VEuPathDB; HostDB:ENSG00000125648; -.
DR   eggNOG; KOG0036; Eukaryota.
DR   GeneTree; ENSGT00940000159428; -.
DR   HOGENOM; CLU_015166_2_0_1; -.
DR   InParanoid; Q9BV35; -.
DR   OMA; MGLLRHI; -.
DR   OrthoDB; 1330359at2759; -.
DR   PhylomeDB; Q9BV35; -.
DR   TreeFam; TF313492; -.
DR   PathwayCommons; Q9BV35; -.
DR   SignaLink; Q9BV35; -.
DR   BioGRID-ORCS; 79085; 9 hits in 1159 CRISPR screens.
DR   ChiTaRS; SLC25A23; human.
DR   GenomeRNAi; 79085; -.
DR   Pharos; Q9BV35; Tbio.
DR   PRO; PR:Q9BV35; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9BV35; protein.
DR   Bgee; ENSG00000125648; Expressed in nucleus accumbens and 183 other tissues.
DR   ExpressionAtlas; Q9BV35; baseline and differential.
DR   Genevisible; Q9BV35; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0000295; F:adenine nucleotide transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0140988; F:ADP:inorganic phosphate antiporter activity; IDA:UniProtKB.
DR   GO; GO:0005347; F:ATP transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0140987; F:ATP:inorganic phosphate antiporter activity; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; TAS:UniProtKB.
DR   GO; GO:0051503; P:adenine nucleotide transport; IDA:UniProtKB.
DR   GO; GO:0015866; P:ADP transport; IBA:GO_Central.
DR   GO; GO:0015867; P:ATP transport; IBA:GO_Central.
DR   GO; GO:0036444; P:calcium import into the mitochondrion; IMP:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:1990544; P:mitochondrial ATP transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006851; P:mitochondrial calcium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IMP:UniProtKB.
DR   GO; GO:1900069; P:regulation of cellular hyperosmotic salinity response; IMP:UniProtKB.
DR   GO; GO:0002082; P:regulation of oxidative phosphorylation; IEA:Ensembl.
DR   GO; GO:0051282; P:regulation of sequestering of calcium ion; IEA:Ensembl.
DR   GO; GO:0003014; P:renal system process; IEA:Ensembl.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 2.
DR   Gene3D; 1.50.40.10; Mitochondrial carrier domain; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR002067; Mit_carrier.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom_sf.
DR   PANTHER; PTHR24089:SF196; CALCIUM-BINDING MITOCHONDRIAL CARRIER PROTEIN SCAMC-3; 1.
DR   PANTHER; PTHR24089; SOLUTE CARRIER FAMILY 25; 1.
DR   Pfam; PF13202; EF-hand_5; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00926; MITOCARRIER.
DR   SMART; SM00054; EFh; 3.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF103506; Mitochondrial carrier; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiport; Calcium; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion inner membrane; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..468
FT                   /note="Mitochondrial adenyl nucleotide antiporter SLC25A23"
FT                   /id="PRO_0000317609"
FT   TOPO_DOM        1..188
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   TRANSMEM        189..206
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        207..243
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   TRANSMEM        244..263
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        264..286
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   TRANSMEM        287..300
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        301..336
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   TRANSMEM        337..356
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        357..379
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   TRANSMEM        380..397
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        398..436
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   TRANSMEM        437..456
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        457..468
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305|PubMed:15123600"
FT   DOMAIN          9..44
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          77..112
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          113..148
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REPEAT          183..269
FT                   /note="Solcar 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00282"
FT   REPEAT          277..362
FT                   /note="Solcar 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00282"
FT   REPEAT          374..462
FT                   /note="Solcar 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00282"
FT   REGION          1..149
FT                   /note="Regulatory N-terminal domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NUK1"
FT   REGION          34..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          150..159
FT                   /note="Linker region"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NUK1"
FT   REGION          165..468
FT                   /note="C-terminal transmembrane transporter domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q6NUK1"
FT   BINDING         22
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         24
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         26
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         28
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         33
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         90
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         92
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         94
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         96
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         101
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   VAR_SEQ         161
FT                   /note="T -> TLSSAGFSAWIKDSTAEQNRSKTTVLARRSGSHLKSQHFGRPKWADH
FT                   E (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_031074"
FT   VAR_SEQ         408..468
FT                   /note="ASIEGGPQLSMLGLLRHILSQEGMRGLYRGIAPNFMKVIPAVSISYVVYENM
FT                   KQALGVTSR -> DVSVYKTDTVPTLIELTGRRGRKMLNKSFWN (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15716113"
FT                   /id="VSP_031075"
FT   VAR_SEQ         408..468
FT                   /note="ASIEGGPQLSMLGLLRHILSQEGMRGLYRGIAPNFMKVIPAVSISYVVYENM
FT                   KQALGVTSR -> GWSTVARFQITATSAFQVQAILLPQPPE (in isoform 3 and
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15801905"
FT                   /id="VSP_031076"
FT   MUTAGEN         22
FT                   /note="D->A: Abolishes the ability to regulate
FT                   mitochondrial calcium uptake; when associated with K-33;
FT                   A-90 and K-101."
FT                   /evidence="ECO:0000269|PubMed:24430870"
FT   MUTAGEN         33
FT                   /note="E->K: Abolishes the ability to regulate
FT                   mitochondrial calcium uptake; when associated with A-22;
FT                   A-90 and K-101."
FT                   /evidence="ECO:0000269|PubMed:24430870"
FT   MUTAGEN         90
FT                   /note="D->A: Abolishes the ability to regulate
FT                   mitochondrial calcium uptake; when associated with A-22;
FT                   K-33 and K-101."
FT                   /evidence="ECO:0000269|PubMed:24430870"
FT   MUTAGEN         101
FT                   /note="E->K: Abolishes the ability to regulate
FT                   mitochondrial calcium uptake; when associated with A-22;
FT                   K-33 and A-90."
FT                   /evidence="ECO:0000269|PubMed:24430870"
SQ   SEQUENCE   468 AA;  52378 MW;  B2D66A4665C27174 CRC64;
     MRGSPGDAER RQRWGRLFEE LDSNKDGRVD VHELRQGLAR LGGGNPDPGA QQGISSEGDA
     DPDGGLDLEE FSRYLQEREQ RLLLMFHSLD RNQDGHIDVS EIQQSFRALG ISISLEQAEK
     ILHSMDRDGT MTIDWQEWRD HFLLHSLENV EDVLYFWKHS TVLDIGECLT VPDEFSKQEK
     LTGMWWKQLV AGAVAGAVSR TGTAPLDRLK VFMQVHASKT NRLNILGGLR SMVLEGGIRS
     LWRGNGINVL KIAPESAIKF MAYEQIKRAI LGQQETLHVQ ERFVAGSLAG ATAQTIIYPM
     EVLKTRLTLR RTGQYKGLLD CARRILEREG PRAFYRGYLP NVLGIIPYAG IDLAVYETLK
     NWWLQQYSHD SADPGILVLL ACGTISSTCG QIASYPLALV RTRMQAQASI EGGPQLSMLG
     LLRHILSQEG MRGLYRGIAP NFMKVIPAVS ISYVVYENMK QALGVTSR
//
